ACIU — AC Immune SA Share News
0.000.00%
Last trade - 00:00- $260.54m
- $173.47m
- CH₣3.57m
Factbox: Companies in Alzheimer's race after US nod for Eisai/Biogen drug
AC Immune up on FDA's 'fast-track' tag for Alzheimer's disease therapy
Brief: AC Immune Receives FDA Fast Track Designation For Anti-Amyloid-Beta Active Immunotherapy, ACI-24.060 To Treat Alzheimer’S Disease
Brief: AC Immune Reports First Quarter 2023 Financial Results
AC Immune SA expected to post a loss of 23 rappen a share - Earnings Preview
AC Immune SA reports results for the quarter ended in December - Earnings Summary
Brief: AC Immune Reports Full Year 2022 Financial Results And Provides Corporate Update
AC Immune SA expected to post a loss of 25 rappen a share - Earnings Preview
Brief: AC Immune Awarded New Grants From Mjff And Target Als Supporting Programs Targeting Tdp-43
U.S. STOCKS ON THE MOVE-Foot Locker, Nemaura, Chipotle
U.S. STOCKS ON THE MOVE-TD Synnex, Nucor, Pfizer
U.S. STOCKS ON THE MOVE-Xerox, AC Immune, OpGen
AC Immune rises as Alzheimer's vaccine shows promise in early-stage study
Brief: Ac Immune Partner Life Molecular Imaging Initiates Phase 3 Study For Alzheimer’S Disease Drug
U.S. STOCKS ON THE MOVE-Viridian, Carvana, Titan Machinery
U.S. STOCKS ON THE MOVE-3M Co, copper miners, Build-A-Bear Workshop
U.S. STOCKS ON THE MOVE-Crypto stocks, gold miners, Horizon Therapeutics
AC Immune rises as Alzheimer vaccine set for development
Brief: Ac Immune’S Alzheimer’S Disease Vaccine-Candidate Selected For Further Development